Document Detail

Lady Prelox® improves sexual function in post-menopausal women.
MedLine Citation:
PMID:  23138717     Owner:  NLM     Status:  Publisher    
AIM:he aim of this pilot, single-blinded study was to evaluate the efficacy of a proprietary, dietary supplement Lady Prelox® for supporting and improving sexual function in generally healthy, post-menopausal women. METHODS: The Lady Prelox® and placebo control groups were comparable at inclusion with regard to the total Female Sexual Function Index (FSFI) score, as well as for the six individual FSFI domains, with 40 women (50.1±3.1 years) and 43 women (51.2±2.3 years), respectively. RESULTS:At baseline the women in the verum group presented with a mean total FSFI score of 44.6±24.1 which increased significantly already after four weeks treatment with Lady Prelox® to 70.9±18.5 and further increased to 71.7±23.9 after completion of the eight-week trial period. In the control group the mean total FSFI was 44.1±22.8 at inclusion and non-significantly increased to 45±21.4 after four weeks and 47.4±21.8 after eight weeks, respectively. The treatment with Lady Prelox® was comparatively significantly more effective than placebo after both four and eight weeks of treatment (P<0.05). The individual six FSFI domains related to desire, arousal, lubrication, orgasm, satisfaction and pain did all respond favourably to treatment with Lady Prelox®; however, with only marginable higher scores in the placebo group. Four women in each group dropped out because of inabilities to attend scheduled check-ups. No adverse effects were reported. CONCLUSION: This study opens an interesting perspective for women experiencing moderate sexual function impairment and suggests a promising new treatment option. Further studies with larger numbers of women, including also premenopausal and perimenopausal women are warranted.
A Bottari; G Belcaro; A Ledda; M R Cesarone; G Vinciguerra; A Di Renzo; S Stuard; M Dugall; L Pellegrini; S Errichi; G Gizzi; E Ippolito; A Ricci; M Cacchio; I Ruffini; F Fano; M Hosoi
Related Documents :
23220167 - Waist-to-hip ratio, but not body mass index, is associated with an increased risk of ba...
15527877 - Occupations and parkinson's disease: a multi-center case-control study in south korea.
23200687 - Do infertile women and their partners have equal experiences with fertility care?
23031847 - Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta...
16369197 - Epidemiology of the metabolic syndrome in 2045 french military personnel (epimil study).
15583577 - Risk factors associated with striae gravidarum.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-09
Journal Detail:
Title:  Panminerva medica     Volume:  -     ISSN:  1827-1898     ISO Abbreviation:  Panminerva Med     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421110     Medline TA:  Panminerva Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Irvine3 Circulation-Vascular Labs, Department of Biomedical Sciences, Chieti-Pescara University, Pescara, Italy -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Synthesis of blue emitting InP/ZnS quantum dots through control of competition between etching and g...
Next Document:  Forskolin and rutin prevent intraocular pressure spikes after Nd:YAG laser iridotomy.